Full Text View
Tabular View
Study Results
Related Studies
Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)
This study has been completed.
Study NCT00724958   Information provided by Merck Sharp & Dohme Corp.

First Received on July 25, 2008.   Last Updated on October 1, 2015   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial